Melanoma Journal Articles September 2019

Dove Press

A new strategy for accurate targeted diagnosis and treatment of cutaneous malignant melanoma: dual-mode phase-change lipid nanodroplets as ultrasound contrast agents

Authors Yang H, Cai W, Lv W, Zhao P, Shen Y, Zhang L, Ma B, Yuan L, Duan Y, Yao K

Received 3 March 2019

Accepted for publication 1 July 2019

Published 2 September 2019 Volume 2019:14 Pages 7079—7093

DOI https://doi.org/10.2147/IJN.S207419


Cancer Letters

Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment

RamounaVoshtania MeiSongb HuanWanga XiaoqiLia WeiZhangc Mojdeh S.Tavallaied WenjunYana JosephSune FangWeia XiaojingMaab

https://doi.org/10.1016/j.canlet.2019.08.018


Future Medicine

Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma

Kristy K Broman  & Jonathan S Zager

Published Online: 2 Sep 2019    https://doi.org/10.2217/mmt-2019-0006


Cancer Immunology Research

STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity

Rana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N Barber and James J Mulé

DOI: 10.1158/2326-6066.CIR-19-0229


BioRxiv

Targeting effector pathways in RAC1P29S-driven malignant melanoma

Cristina Uribe-Alvarez, Sandra Lucía Guerrero-Rodríguez, Jennifer Rhodes, Alexa Cannon,  View ORCID ProfileJonathan Chernoff, Daniela Araiza-Olivera

doi: https://doi.org/10.1101/750489


JAMA Dermatology

Evolution of Excisional Surgery Practices for Melanoma in the United States

Michael P. Lee, BS1Joseph F. Sobanko, MD2Thuzar M. Shin, MD, PhD2; et al

JAMA Dermatol. Published online August 28, 2019. doi:10.1001/jamadermatol.2019.2346


Journal of Extracellular Vesicles

Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma

Su Chul Jang,Rossella Crescitelli,Aleksander Cvjetkovic,Valerio Belgrano,Roger Olofsson Bagge,Karin Sundfeldt, show all

Article: 1635420 | Received 12 May 2018, Accepted 14 Jun 2019, Published online: 27 Aug 2019


British Medical Journal

Diffuse melanosis cutis

BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4901 (Published 05 September 2019)Cite this as: BMJ 2019;366:l4901


Antibiotocs

Article Tobramycin Promotes Melanogenesis by Upregulating p38 MAPK Protein Phosphorylation in B16F10 Melanoma Cells

Seung-Hyun Moon, You Chul Chung and Chang-Gu Hyun *

Department of Chemistry and Cosmetics, Jeju National University, Jeju 63243, Korea *

Received: 26 July 2019; Accepted: 2 September 2019; Published: 5 September 2019

Antibiotics 2019, 8, 140; doi:10.3390/antibiotics8030140


Current Oncology

Practice Guideline


Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline

 

F.C. Wright, MEd MD*, L.H. Souter, PhD, S. Kellett, MEnvSc, A. Easson, MD MSc, C. Murray, MD§, J. Toye, MD||, D. McCready, MD MSc, C. Nessim, MD#, D. Ghazarian, MD**, N.J. Look Hong, MD MSc††, S. Johnson, MD#, D.P. Goldstein, MD**, T. Petrella, MD*, the Melanoma Disease Site Group

doi: http://dx.doi.org/10.3747/co.26.4885


JAAD

Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring

Aimilios Lallas, PhD1, , Zoe Apalla, PhD2Athanassios Kyrgidis, PhD3Chryssoula Papageorgiou, MD1Ioannis Boukovinas, MD4Mattheos Bobos, PhD5George Efthimiopoulos, MD6Christina Nikolaidou, MD7Andreas Moutsoudis, MD1Theodosia Gkentsidi, MD1Konstantinos Lallas, MD1Elizabeth Lazaridou, PhD8Elena Sotiriou, PhD1Efstratios Vakirlis, PhD1Dimitrios Ioannides, PhD1

DOI: https://doi.org/10.1016/j.jaad.2019.08.074


Journal of Experimental and Clinical Cancer Research

IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression

Journal of Experimental & Clinical Cancer Research volume 38, Article number: 397 (2019)  https://doi.org/10.1186/s13046-019-1403-9


Cancers

Review Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside

Taku Fujimura 1,* , Yasuhiro Fujisawa 2 , Yumi Kambayashi 1 and Setsuya Aiba 1

Received: 29 August 2019; Accepted: 9 September 2019; Published: 11 September 2019


Clinical Cancer Research

High-Plex Predictive Marker Discovery for Melanoma Immunotherapy–Treated Patients Using Digital Spatial Profiling

Maria I. Toki, Christopher R. Merritt, Pok Fai Wong, James W. Smithy, Harriet M. Kluger, Konstantinos N. Syrigos, Giang T. Ong, Sarah E. Warren, Joseph M. Beechem and David L. Rimm

DOI: 10.1158/1078-0432.CCR-19-0104 Published September 2019


Molecular Cancer Therapeutics

Research Article

Utility of the RIG-I agonist triphosphate RNA for melanoma therapy

Mike W Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, Christiane Metz-Weidmann, Monika Braun, Gabriele Dietert, Petra Scherer, Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R. Wagenaar, Max M. Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner and Lars M. König

DOI: 10.1158/1535-7163.MCT-18-1262

Published Online First September 12, 2019


Food and Beverage Consumption and Melanoma Risk: A Population-Based Case-Control Study in Northern Italy

by Carlotta Malagoli 1,Marcella Malavolti 1,Francesca Farnetani 2,Caterina Longo 2,Tommaso Filippini 1,Giovanni Pellacani 2 andMarco Vinceti 1,3,*

 

Nutrients 201911(9), 2206; https://doi.org/10.3390/nu11092206

Received: 19 July 2019 / Revised: 9 September 2019 / Accepted: 10 September 2019 / Published: 12 September 2019


British Journal of Dermatology

A risk prediction model for development of subsequent primary melanoma in a population?based cohort

A.E. Cust C. Badcock J Smith N.E. Thomas L.E. Haydu B.K. Armstrong M.H. Law J.F. Thompson P.A. Kanetsky C.B. Begg Y. Shi A. Kricker I. Orlow A. Sharma S. Yoo S.F. Leong  

First published: 14 September 2019

https://doi.org/10.1111/bjd.18524


Molecular Cancer Therapeutics

Distinct transcriptional programming drive response to MAPK inhibition in BRAFV600 mutant melanoma patient derived xenografts

Tianshu Feng, Javad Golji, Ailing Li, Xiamei Zhang, David A. Ruddy, Daniel P Rakiec, Felipe C. Geyer, Jane Gu, Hui Gao, Juliet A Williams, Darrin D. Stuart and Matthew J Meyer

DOI: 10.1158/1535-7163.MCT-19-0028

 


A meta?analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival

  1. MoscarellaR. PampenaG. Palmiotti D. Bonamonte G. Brancaccio V. Piccolo C. Longo G. Argenziano

First published: 23 August 2019

https://doi.org/10.1111/jdv.15903


Journal of Pineal Research

ORIGINAL ARTICLE

 

Full Access

Melatonin exerts oncostatic capacity and decreases melanogenesis in human MNT?1 melanoma cells

Konrad Kleszczy?ski Tae?Kang Kim Bernadetta Bilska Michal Sarna Krystian Mokrzynski Agatha Stegemann El?bieta Pyza Russel J. Reiter Kerstin Steinbrink Markus Böhm Andrzej T. Slominski

First published: 18 September 2019

https://doi.org/10.1111/jpi.12610


British Journal of Dermatology

The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population?based matched cohort study in Korea

H.S. Kim H.J. Kim E.S. Hong K.B. Kim J.D. Lee T.U. Kang H.S. Ahn

First published: 24 June 2019

https://doi.org/10.1111/bjd.18247


JMRI

Susceptibility?weighted imaging in malignant melanoma brain metastasis

Daniel Schwarz MD Thomas Niederle Philipp Münch Thomas Hielscher MSc Jessica C. Hassel MD Heinz?Peter Schlemmer MD Michael Platten MD Frank Winkler MD  See all authors 

First published: 21 February 2019

https://doi.org/10.1002/jmri.26692


Cancer Immunology Research

STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity

Rana Falahat, Patricio Perez-Villarroel, Adam W. Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N. Barber and James J. Mulé

DOI: 10.1158/2326-6066.CIR-19-0229


Pigment Cell & Melanoma

A genome?wide CRISPR screen identifies FBXO42 involvement in resistance towards MEK inhibition in NRAS mutant melanoma

Adi Nagler David W. Vredevoogd Michal Alon Phil F. Cheng Sophie Trabish Shelly Kalaora Rand Arafeh Victoria Goldin Mitchell P. Levesque Daniel S. Peeper Yardena Samuels

First published: 24 September 2019

https://doi.org/10.1111/pcmr.12825


British Journal of Dermatology

Development and external validation study of a melanoma risk prediction model incorporating clinically assessed naevi and solar lentigines

  1. VuongB.K. ArmstrongM. Drummond J.L. Hopper J.H. Barrett J.R. Davies D.T. Bishop J. Newton?Bishop J.F. Aitken G.G. Giles H. Schmid M.A. Jenkins G.J. Mann K. McGeechan A.E. Cust

First published: 04 August 2019  https://doi.org/10.1111/bjd.18411


Ears, Nose and Throat Journal

Sex- and Site-Related Significance in Cutaneous Head and Neck Melanoma

Andro Košec, MD, PhD, FEBORL-HNS, Ivan Raši?, MD, PhD, Alan Pegan, MD, PhD, …

https://doi.org/10.1177/0145561319875949

First Published September 23, 2019


Translational Cancer Research

 

MicroRNA-204-3p modulates epithelial-mesenchymal transition by targeting paired box gene 2 in human melanoma A-375 cells

Authors: Jun Song, Xinyan Chen, Liping Zhang, Dandan Song, Huizi Xiong

Vol 8, No 5 (September 2019) 


New England Journal of Medicine

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

  • James Larkin, F.R.C.P., Ph.D.,
  • Vanna Chiarion-Sileni, M.D.,
  • Rene Gonzalez, M.D.,
  • Jean-Jacques Grob, M.D.,
  • Piotr Rutkowski, M.D., Ph.D.,
  • Christopher D. Lao, M.D.,
  • Lance Cowey, M.D., M.P.H.,
  • Dirk Schadendorf, M.D.,
  • John Wagstaff, M.D.,
  • Reinhard Dummer, M.D.,
  • Pier F. Ferrucci, M.D.,
  • Michael Smylie, M.D.,

Et al.

 

September 28, 2019
DOI: 10.1056/NEJMoa1910836


British Journal of Dermatology

Clinicopathological factors associated with death from thin (?1.00mm) melanoma

  1. ClaesonP. BaadeS. Brown H.P. Soyer B.M. Smithers A.C. Green D.C. Whiteman K. Khosrotehrani

First published: 28 September 2019

https://doi.org/10.1111/bjd.18560


Chemico-Biological Interactions

Available online 30 September 2019, 108822

Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes

Author links open overlay panelJenny MaeSamsona1Dinoop RavindranMenona1Derek E.Smithb1ErikaBairdaTakayukiKitanoacDexiangGaobAik-ChoonTandMayumiFujitaaef

https://doi.org/10.1016/j.cbi.2019.108822


Journal of Investigative Dermatology

Available online 30 September 2019

MicroRNA Ratios Distinguish Melanomas from Nevi

Author links open overlay panelRodrigoTorres1Ursula E.Lang12MiroslavHejna34Samuel J.Shelton5Nancy M.Joseph2A. HunterShain1IweiYeh12Maria L.Wei16Michael C.Oldham5Boris C.Bastian12Robert L.Judson-Torres178

Show more

https://doi.org/10.1016/j.jid.2019.06.126


Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland

Edoardo Botteri, Nathalie C. Støer, Elisabete Weiderpass, Eero Pukkala, Olavi Ylikorkala and Heli Lyytinen

DOI: 10.1158/1055-9965.EPI-19-0554

Published Online First September 30, 2019
doi: 10.1158/1055-9965.EPI-19-0554


EBio Medicine

 

Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma

Inna Smalleya , Eunjung Kimb , Jiannong Lic , Paige Spencea , Clayton J. Wyatta , Zeynep Eroglud, Vernon K. Sondakd, Jane L. Messinad,e , Nalan Akgul Babacand, Silvya Stuchi Maria-Englerf , Lesley De Armasg , Sion L. Williamsg , Robert A. Gatenbyc , Y. Ann Chenc,? , Alexander R.A. Andersonb,? , Keiran S.M. Smalleya,d,??

 

Received 21 June 2019 Revised 13 September 2019 Accepted 13 September 2019

https://doi.org/10.1016/j.ebiom.2019.09.023